- Home
- ECBK vs BTMD Comparison
ECBK vs BTMD Comparison
Compare ECBK & BTMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ECBK
- BTMD
- Stock Information
- Founded
- ECBK 1919
- BTMD 2012
- Country
- ECBK United States
- BTMD United States
- Employees
- ECBK N/A
- BTMD N/A
- Industry
- ECBK Banks
- BTMD Medicinal Chemicals and Botanical Products
- Sector
- ECBK Finance
- BTMD Health Care
- Exchange
- ECBK Nasdaq
- BTMD Nasdaq
- Market Cap
- ECBK 151.0M
- BTMD 127.8M
- IPO Year
- ECBK N/A
- BTMD N/A
- Fundamental
- Price
- ECBK $17.05
- BTMD $3.49
- Analyst Decision
- ECBK
- BTMD Buy
- Analyst Count
- ECBK 0
- BTMD 2
- Target Price
- ECBK N/A
- BTMD $6.00
- AVG Volume (30 Days)
- ECBK 9.4K
- BTMD 225.3K
- Earning Date
- ECBK 10-23-2025
- BTMD 08-06-2025
- Dividend Yield
- ECBK N/A
- BTMD N/A
- EPS Growth
- ECBK 52.06
- BTMD 642.53
- EPS
- ECBK 0.64
- BTMD 0.88
- Revenue
- ECBK $27,795,000.00
- BTMD $199,073,000.00
- Revenue This Year
- ECBK N/A
- BTMD N/A
- Revenue Next Year
- ECBK N/A
- BTMD $4.85
- P/E Ratio
- ECBK $26.58
- BTMD $3.96
- Revenue Growth
- ECBK 12.29
- BTMD 6.32
- 52 Week Low
- ECBK $12.56
- BTMD $2.76
- 52 Week High
- ECBK $17.33
- BTMD $6.98
- Technical
- Relative Strength Index (RSI)
- ECBK 61.32
- BTMD 50.45
- Support Level
- ECBK $16.82
- BTMD $2.84
- Resistance Level
- ECBK $17.17
- BTMD $3.60
- Average True Range (ATR)
- ECBK 0.25
- BTMD 0.19
- MACD
- ECBK 0.03
- BTMD 0.07
- Stochastic Oscillator
- ECBK 72.55
- BTMD 79.22
About ECBK ECB Bancorp Inc.
ECB Bancorp Inc operates as a bank holding company of Everett Co-operative Bank. The firm through its subsidiary engages in business consisting of taking deposits from the general public and investing those deposits, together with funds generated from operations, in one- to four-family residential real estate loans, commercial real estate, and multifamily real estate loans, construction and land loans and home equity lines of credit.
About BTMD Biote Corp.
Biote Corp operates a growth practice-building business within the hormone optimization space. It provides the necessary components to enable Biote-certified practitioners to establish, build, and successfully implement a program designed to optimize hormone levels using personalized solutions for their patient populations. The company derives revenue from United States and also has its presence in other countries.